Navigation Links
IFC to Invest About Rs.3 Billion in Max Healthcare

International Finance Corp. (IFC), the private sector division of World Bank, Monday announced its plans to invest Rs.3 billion in India's Max Healthcare Institute for its expansion plans.

Max Healthcare Institute is a subsidiary of Max India, a multi-business company with interests in life insurance, health care, clinical research, and specialty plastics.

"While the government is focusing its resources on increasing services to the rural areas, it is critical for the private sector to complement the public sector by expanding access to meet the demand," Guy Ellena, IFC director for health and education, said in a statement here.

The proposed expansion will add 452 beds to Max Healthcare's existing 765-bed capacity in its hospitals. It will also include adding 268 beds to its Patparganj unit here; a new 100-bed secondary and tertiary hospital in Dehradun; and an 84-bed tertiary hospital focused on obstetrics, gynaecology, and paediatrics at its Saket branch in south Delhi.

The project is also expected to create 4,500 jobs in the medical industry during the construction phase.

"Max Healthcare is proud to partner with IFC. This partnership recognizes our efforts to establish benchmarks of medical excellence and outstanding quality of service," said Max India chairman Analjit Singh.

"IFC's investment will help us realize our vision of emerging as one of India's leading healthcare providers," Singh added.

IFC, which supports private sector-led development through direct investment to promote growth, has invested over 400 million dollars in various projects across India in the 2005-06 fiscal.


'"/>




Page: 1

Related medicine news :

1. Invest on gym memberships
2. Investigations That Help Detect Lung Disease
3. Sitagliptin, Under Investigation For Type 2 Diabetes
4. China Doubles Its Investment In AIDS/HIV Treatment.
5. Biocon To Raise Its Investment In Scotland
6. Cocoa Treats: Chocolates, as a Health Investment? Chew on this!
7. President Bush Urges Citizens to Invest In Health Savings Account (HSAs)
8. Doctor Accused Of Misdiagnosing 208 Patients: Further Investigation Ordered
9. Legionnaires Investigation in Chatswoods Shopping Area
10. New Multi-functional Sensing Tool To Investigate Cystic Fibrosis
11. Investigation to identify the source of HIV infection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal ... to the end of November. , The Chicago, Illinois, based self-defense brand has been ... them about the ease of taking their personal safety into their own hands. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and continued ... have been awarded five-year accreditation status through the Public Health Accreditation Board ... by a PHAB-accredited health department now extend to more than 203 million ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition to sticking with ... more holistic approach and use natural alternatives for all house cleaning products, disinfectants, ... USDA guaranteeing that, the new line of essential oils, are all 100% organic ...
(Date:9/21/2017)... ... 2017 , ... The New England Center for Children® (NECC®), a global leader ... Hung to the Board of Directors. , “The New England Center for Children ... an invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: